Cystatin C, renal disease, amyloidosis and antibiotics
31 – 40 of 134
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Prospects for improved glomerular filtration rate estimation based on creatinine—results from a transnational multicentre study
(
- Contribution to journal › Article
-
Mark
Structural characterization of covalently stabilized human cystatin c oligomers
(
- Contribution to journal › Article
-
Mark
Performance of Indexed and Nonindexed Estimated GFR
(
- Contribution to journal › Letter
-
Mark
Shrunken pore syndrome and mortality : a cohort study of patients with measured GFR and known comorbidities
(
- Contribution to journal › Article
-
Mark
A novel method for creatinine adjustment makes the revised Lund–Malmö GFR estimating equation applicable in children
(
- Contribution to journal › Article
- 2019
-
Mark
Validation of standardized creatinine and cystatin C GFR estimating equations in a large multicentre European cohort of children
2019) In Pediatric Nephrology(
- Contribution to journal › Article
-
Mark
Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins
(
- Contribution to journal › Article
-
Mark
Krympt por-syndrom – ett nyupptäckt syndrom med hög prevalens och mortalitet
(
- Contribution to journal › Scientific review
-
Mark
CKD : A Call for an Age-Adapted Definition
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Cystatin C as a Multifaceted Biomarker in Kidney Disease and Its Role in Defining "Shrunken Pore Syndrome"
2017) p.225-240(
- Chapter in Book/Report/Conference proceeding › Book chapter